• Mon espace de travail
  • Aide IRIS
  • Par Publication Par Personne Par Unité
    • English
    • Français
  • Se connecter
Logo du site

IRIS | Système d’Information de la Recherche Institutionnelle

  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
UNIL
  • English
  • Français
Se connecter
IRIS
  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
  • Mon espace de travail
  • Aide IRIS

Parcourir IRIS

  • Par Publication
  • Par Personne
  • Par Unité
  1. Accueil
  2. IRIS
  3. Publication
  4. Effet anti-inflammatoire du diclofenac sodium topique (Voltarène Ophta) après trabéculoplastie au laser argon (TLA): résultats préliminaires d'une étude prospective en double-insu [Anti-inflammatory effect of topical diclofenac sodium (Voltarène Ophta) after argon laser trabeculoplasty: preliminary results of a prospective double-blind method].
 
  • Détails
Titre

Effet anti-inflammatoire du diclofenac sodium topique (Voltarène Ophta) après trabéculoplastie au laser argon (TLA): résultats préliminaires d'une étude prospective en double-insu [Anti-inflammatory effect of topical diclofenac sodium (Voltarène Ophta) after argon laser trabeculoplasty: preliminary results of a prospective double-blind method].

Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Klinische Monatsblätter für Augenheilkunde  
Auteur(s)
Herbort, C.P.
Auteure/Auteur
Mermoud, A.
Auteure/Auteur
Schnyder, C.
Auteure/Auteur
Pittet, N.
Auteure/Auteur
Liens vers les personnes
Mermoud, André  
Liens vers les unités
Hôpital ophtalmique Jules Gonin  
ISSN
0023-2165
Statut éditorial
Publié
Date de publication
1992-05
Volume
200
Numéro
5
Première page
358
Dernière page/numéro d’article
361
Langue
français
Notes
Publication types: Clinical Trial ; English Abstract ; Journal Article ; Randomized Controlled Trial
Publication Status: ppublish
Résumé
Using the laser flare-cell meter (LFMC), we have previously determined the intensity and pattern of post-ALT ocular inflammation. Inflammation peak occurs 48 hours after ALT and clinically relevant inflammation is seen in 100% of pigmentary glaucomas (PIG), 75% of pseudoexfoliative glaucomas (PEXG) but only in 25% of primary open angle glaucomas (POAG). We also showed that topical diclofenac reduced inflammation in all 17 treated patients. Prostaglandins are thought to play a major role in ALT-inflammation and it is therefore logical to assume that NSAID are effective in that situation and will probably advantageously replace corticosteroids. In order to assess the anti-inflammatory effect of diclofenac drops (Voltaren Ophtha) we included a total of 37 PIG or PEXG (19 in the diclofenac and 18 in the placebo group) scheduled for ALT in prospective randomized placebo-controlled study. Visual acuity, tonometry, and LFCM flare measure were performed before, 3, 6 hours, 1, 2, 4, 7, 14 days after ALT. Topical diclofenac or placebo was given before and after ALT and then QID for a total of 4 days. Mean maximal flare increase was significantly less in the diclofenac group than in the placebo group (4.6 +/- 3.8 ph/msec v. 17.4 +/- 19 ph/msec; p less than 0.01). Flare increase compared to pre-ALT values was significant at 1 and 2 days after ALT in the placebo group only (p less than 0.02; p less than 0.05); no significant flare increase occurred in the diclofenac group.(ABSTRACT TRUNCATED AT 250 WORDS)
Sujets

Aged

Anterior Chamber/drug...

Diclofenac/administra...

Double-Blind Method

Female

Glaucoma/surgery

Glaucoma, Open-Angle/...

Humans

Inflammation

Intraocular Pressure/...

Laser Therapy

Male

Ophthalmic Solutions

Postoperative Complic...

Trabeculectomy

PID Serval
serval:BIB_80FABC44B7EC
DOI
10.1055/s-2008-1045765
PMID
1614100
WOS
A1992HV60100008
Permalien
https://iris.unil.ch/handle/iris/144352
Date de création
2008-01-28T11:49:31.911Z
Date de création dans IRIS
2025-05-20T21:59:08Z
  • Copyright © 2024 UNIL
  • Informations légales